The role of prophylactic mesh placement to prevent incisional hernia in laparotomy. Is it time to change practice?


Journal

Anaesthesiology intensive therapy
ISSN: 1731-2531
Titre abrégé: Anaesthesiol Intensive Ther
Pays: Poland
ID NLM: 101472620

Informations de publication

Date de publication:
2019
Historique:
pubmed: 14 9 2019
medline: 29 8 2020
entrez: 14 9 2019
Statut: ppublish

Résumé

Incisional hernia (IH) occurs in approximately 25% of laparotomies. Prophylactic mesh placement (PMP) may significantly reduce IH but is not widely used. This paper will review the evidence relating to the role of PMP in laparotomy and its ability to effectively and safely have an impact on hernia reduction. An ethically approved review of all published English articles relating to IH prevention following laparotomy was undertaken at Letterkenny University Hospital by searching PubMed, Scopus, and electronic databases over a 20-year period from January 1999 to March 2019. The search terms "incisional hernia", "laparotomy", "mesh placement", "reoperation", "readmitted", and "rates" were used in combination. The literature identified 17 publications, of which 14 were randomised, controlled trials and three were prospective cohort studies from 22 countries. Bariatric surgery accounted for eight of the 17 studies. Onlay mesh placement was used in five studies. Preperitoneal, retrorectus, intra-peritoneal, combinations of and sublay were used in 4, 3, 2, 2, and 1 studies, respectively. In two studies both sublay and onlay were performed. A total of 2777 patients were reported. One study had two publications with different lengths of follow-up. Currently surgeons need to consider changing practice to firstly ensure they practice optimum laparotomy closure technique and potentially use PMP. If not using PMP they need to question why, because PMP will more than halve the IH rate, especially in higher risk patients undergoing laparotomy.

Sections du résumé

BACKGROUND
Incisional hernia (IH) occurs in approximately 25% of laparotomies. Prophylactic mesh placement (PMP) may significantly reduce IH but is not widely used. This paper will review the evidence relating to the role of PMP in laparotomy and its ability to effectively and safely have an impact on hernia reduction.
METHODS
An ethically approved review of all published English articles relating to IH prevention following laparotomy was undertaken at Letterkenny University Hospital by searching PubMed, Scopus, and electronic databases over a 20-year period from January 1999 to March 2019. The search terms "incisional hernia", "laparotomy", "mesh placement", "reoperation", "readmitted", and "rates" were used in combination.
RESULTS
The literature identified 17 publications, of which 14 were randomised, controlled trials and three were prospective cohort studies from 22 countries. Bariatric surgery accounted for eight of the 17 studies. Onlay mesh placement was used in five studies. Preperitoneal, retrorectus, intra-peritoneal, combinations of and sublay were used in 4, 3, 2, 2, and 1 studies, respectively. In two studies both sublay and onlay were performed. A total of 2777 patients were reported. One study had two publications with different lengths of follow-up.
CONCLUSIONS
Currently surgeons need to consider changing practice to firstly ensure they practice optimum laparotomy closure technique and potentially use PMP. If not using PMP they need to question why, because PMP will more than halve the IH rate, especially in higher risk patients undergoing laparotomy.

Identifiants

pubmed: 31517473
pii: 37490
doi: 10.5114/ait.2019.87475
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-329

Auteurs

Michael Sugrue (M)

Department of Surgery, Letterkenny University Hospital and Donegal Clinical Research Academy, Ireland.
EU INTERREG Centre for Personalised Medicine, Intelligent Systems Research Centre, School of Computing, Engineering, and Intelligent Systems, Ulster University, Magee Campus, Derry-Londonderry, Northern Ireland, United Kingdom.

Alison Johnston (A)

Department of Surgery, Letterkenny University Hospital and Donegal Clinical Research Academy, Ireland.

Saqib Zeeshan (S)

Department of Surgery, Letterkenny University Hospital and Donegal Clinical Research Academy, Ireland.

Paula Loughlin (P)

EU INTERREG Centre for Personalised Medicine, Intelligent Systems Research Centre, School of Computing, Engineering, and Intelligent Systems, Ulster University, Magee Campus, Derry-Londonderry, Northern Ireland, United Kingdom.
Department of Surgery, Altnagelvin Hospital, Derry-Londonderry, Northern Ireland , United Kingdom.

Magda Bucholc (M)

EU INTERREG Centre for Personalised Medicine, Intelligent Systems Research Centre, School of Computing, Engineering, and Intelligent Systems, Ulster University, Magee Campus, Derry-Londonderry, Northern Ireland, United Kingdom.

Angus Watson (A)

EU INTERREG Centre for Personalised Medicine, Intelligent Systems Research Centre, School of Computing, Engineering, and Intelligent Systems, Ulster University, Magee Campus, Derry-Londonderry, Northern Ireland, United Kingdom.
Raighmore Hospital, Inverness, Scotland, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH